Product
Enterovirus Type 71 Vaccine
2 clinical trials
3 indications
Indication
Healthy Control ParticipantsIndication
HandIndication
Foot-and-Mouth DiseaseClinical trial
A Phase 1b Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of Bemarituzumab Monotherapy and Combination With Other Anti-Cancer Therapy in Subjects With Squamous-Cell Non-Small-Cell Lung Cancer (FORTITUDE-201)Status: Active (not recruiting), Estimated PCD: 2024-04-30
Clinical trial
Study on the Immunogenicity and Safety of Inactivated Enterovirus Type 71 Vaccine Combined Administration With Recombinant Hepatitis B and Group A Meningococcal VaccineStatus: Active (not recruiting), Estimated PCD: 2024-12-31